Summary Information:
Qiagen N.V. Common Shares
NYSE:QGEN


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Qiagen N.V. Common Shares
Exchange: NYSE
Symbol: QGEN
SEC CIK: 0001015820
Phone: 31-77-35566-00
HULSTERWEG 82
PL VENLO P7 5912

CEO: Thierry Bernard
Price when page updated: 41.35 Date: 2023-12-03
Company Website:
www.qiagen.com

_Description: QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31, 2020, QIAGEN employed more than 5,600 people in over 35 locations worldwide.

IPO YEAR:

Sector:
Health Care
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
ADRTSO:

MarketCap:
9416222000.00
Beta:
0.3719150651159331
52 Week High:
59
52 Week Low:
45.58
52 Week Change:
0.05448354143019296
Short Interest:

Short Date:

Shares Outstanding:
227985334
Dividend Rate:
0
Dividend Yield:
0.00%
ExDividend Date:

Latest EPS:

Latest EPS Date:
2 Nov 2022
Float:
0
return on Equity:
16.30%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$732.772M
ttmEPS:
2.56
Revenue:
$2.261B
Gross Profit:

Cash:

Debt:

Institution Percent:
68.10%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
3.60%
Return on Assets:
8.40%
Return on Capital:

Profit Margin:
22.70%
Price to Sales:
4.28
Price To Book:
2.93
Short Ratio:
4.37
PE Ratio:
21.31847870175709
Employees:
5610
1Y Guesstimate
53.211:1.0:6




__The following are links to various summary and news pages for
__Qiagen N.V. Common Shares [ QGEN ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-03